Pain management after adrenal tumor surgery
Part of Pain clinical trials.
This trial compares two pain relief methods after surgery to remove an adrenal gland tumor, aiming to find which works better with fewer side effects. It may help reduce discomfort during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 20 years old
- Have a tumor on one adrenal gland that is smaller than 4 cm
- Be scheduled for laparoscopic adrenalectomy (keyhole surgery to remove the tumor)
- Not have other major surgeries planned at the same time
- Not have had previous major surgery on the same side of the abdomen or a history of peritonitis (infection of the abdominal lining)
- Be in generally good health (not classed as severe risk for surgery)
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of minimally invasive surgery (laparoscopic vs robotic) to remove an adrenal gland. It aims to see which approach leads to better recovery and outcomes.
This study looks at how different types of adrenal tumors might affect the heart during and after surgery. It aims to help doctors understand and reduce the risk of heart injury in patients having these tumors removed.
This study looks at how often adrenal insufficiency happens after surgery for primary aldosteronism, especially in patients who also have an overproduction of cortisol. It helps doctors understand if extra hormone support is needed after surgery.
This study tests whether taking a steroid (hydrocortisone) after adrenal gland surgery helps protect kidney function in people with primary aldosteronism and chronic kidney disease. It could slow down further kidney damage.
This trial compares two treatments—ultrasound-guided ablation and laparoscopic adrenalectomy—for a type of adrenal tumor called aldosterone-producing adenoma (APA) that causes high blood pressure and low potassium. The goal is to see which treatment works better for patients with a single, non-cancerous tumor.
This trial compares two ways to treat unilateral primary aldosteronism: taking mineralocorticoid receptor antagonist (MRA) pills or having minimally invasive surgery. It may help decide which option works best and is safest for people who can choose surgery.
Hear when a new Post Operative Pain, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.